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Abstract 
 
Recent reviews have demonstrated that the quality of stroke rehabilitation research has 
continued to improve over the last four decades but despite this progress there are still 
many barriers in moving the field forward. Rigorous development, monitoring and complete 
reporting of interventions in stroke trials are essential in providing rehabilitation evidence 
that is robust, meaningful and implementable.  
An international partnership of stroke rehabilitation experts committed to develop 
consensus-based core recommendations with a remit of addressing the issues identified as 
limiting stroke rehabilitation research in the areas of developing, monitoring and reporting 
stroke rehabilitation interventions. Work exploring each of the three areas took place via 
multiple teleconferences and a two-day meeting in Philadelphia in May 2016.  A total of 15 
recommendations were made. 
To validate the need for the recommendations the group reviewed all stroke rehabilitation 
trials published in 2015 (n=182 papers). Our review highlighted that the majority of 
publications did not clearly describe how interventions were developed or monitored during 
the trial. In particular, under-reporting of the theoretical rationale for the intervention and 
the components of the intervention calls into question many interventions that have been 
evaluated for efficacy. More trials were found to have addressed the reporting of 
interventions recommendations than those related to development or monitoring. 
Nonetheless the majority of reporting recommendations were still not adequately 
described.  
To progress the field of stroke rehabilitation research and to ensure stroke patients receive 
optimal evidence based clinical care we urge the research community to endorse and adopt 
our recommendations. 
  
Introduction 
 
Recovery and a return to a full and meaningful life following stroke is the main goal for 
stroke survivors, their families and the health professionals who strive to provide the best 
care possible. Stroke rehabilitation research has informed our understanding of how we 
enhance recovery following stroke and consequently has helped shape our clinical practice. 
However rigorous evaluation methodologies and complete reporting of such are essential if 
we are to provide evidence that is robust, meaningful and implementable. Recent reviews 
have demonstrated that the quality of stroke rehabilitation research has continued to 
improve over the last four decades(1) but despite this progress there are still many barriers 
in moving the field forward.  
 
In 2015 an international partnership of stroke recovery and rehabilitation experts 
committed to addressing four key areas that require attention from the stroke rehabilitation 
research community(2). These were: the first translational gap; recovery biomarkers; 
intervention development, monitoring and reporting; measurement in clinical trials. This 
paper addresses the theme of developing, monitoring and reporting interventions. It 
highlights issues identified as requiring improvement by an international working group and 
the recommendations made following the first International Stroke Rehabilitation and 
Recovery Roundtable (SRRR) meeting which took place in Philadelphia in May 2016.   
 
Development of interventions 
Stroke rehabilitation interventions are complex and commonly multi-faceted, containing 
many inter-related components with the ultimate aim of addressing specific post-stroke 
problems.  
In order to have confidence in any research findings it is essential that we fully understand 
the theoretical and/or the biological rationale that underpins each intervention. The 
rationale for an intervention is required if we are to clearly understand how it will effect 
change in the population studied. In order to achieve an understanding of the likely process 
of change, researchers should have previously drawn on biological, physical and/or 
psychological rationales, existing evidence from the literature, and from other related 
theories.  
 
Sequential intervention development, which is not necessarily linear, is also important to 
ascertain the optimal patient group to target, the essential core and flexible elements of the 
intervention, how (by whom) it should be delivered, and the optimum dose and frequency; 
which all ultimately inform fidelity assessment. 
Several intervention development frameworks exist to aid researchers and clinicians achieve 
this. One such example would be the Behaviour Change Approach(3).  The most commonly 
referenced framework used in the global stroke community is the MRC Framework for the 
development and evaluation of complex interventions, originally published in 2000(4), 
updated in 2006(5) and is currently undergoing a further update.  
 
Redfern and colleagues (6) used the MRC framework(4) to conduct a systematic review of 
how complex interventions in stroke care had been developed. In this review 67 studies 
were identified of which 39 were randomised controlled trials. This work concluded that 
‘theoretical grounding to support intervention choice was reported in 40 studies but only 14 
were theoretically well developed.’  The authors went on to conclude that few complex 
interventions in stroke care had been sufficiently developed or evaluated using appropriate 
methodology and that this may explain the failure of many studies to demonstrate efficacy.  
 
During the Stroke Recovery and Rehabilitation Roundtable discussions, the consensus of the 
international group was that the findings of Redfern and colleagues were still largely 
applicable. The theoretical and /or biological rationale and sequential development of many 
stroke rehabilitation interventions does not follow a recommended framework for 
development or if a framework is followed then it is not reported in the main study 
publications.  
 
 
Intervention monitoring 
Another problem highlighted by the SRRR working group was the lack of intervention fidelity 
and reporting i.e. whether interventions were delivered as intended, whether their use in 
the context of a particular study or setting was modified to suit the local context (setting or 
therapist) or individually tailored to the person being treated, or of the methods used to 
maintain intervention fidelity during the course of a trial.  
 
As the pre-development work for larger trials often involves multiple, smaller, single centre 
studies, sometimes in different countries, it becomes increasingly important to understand 
the extent to which an intervention delivered in one setting differs from the same 
intervention delivered elsewhere and how it might have been modified to suit the local 
context or person. Similarly the extent to which the training or skills of the therapist differed 
between settings and therefore how it might have influenced the outcome also needs to be 
known.  The Template for Intervention Description and Replication (TIDieR) checklist (items 
5 and 11)(7) prompts researchers to describe these elements where possible. However, if 
researchers fail to recognise potential factors of influence at the design stage they may be 
not collected at all, poorly reported or absent from reports.   
 
Implementation frameworks and intervention fidelity models prompt researchers to 
consider these factors more broadly(8-14).  The Consolidated Framework for 
Implementation Research (CFIR)(10) adopts the metaphor of an arena to highlight factors in 
different contextual areas that can affect fidelity.  Examples of factors in the ‘outer’ setting 
include resources, external policies and incentives, and those in the ‘inner’ setting include 
culture, networks and communication and at an individual level, patients and therapists 
knowledge and beliefs and personal attributes.  The CFIR also recognises the importance of 
‘process’ factors including the extent to which a particular site is engaged and willing to 
execute delivery of the intervention, the competency and skills of people involved in its 
delivery and the characteristics of the interventions itself, such as the strength and quality 
of evidence to support it, its cost and complexity. 
 
Adopting an implementation fidelity model or framework at the design stage may prompt 
stroke rehabilitation researchers to consider which aspects of fidelity are most important, 
which to monitor, and how to do this during the trial. Moreover, they may inform the 
theory by which the intervention works and help to identify mechanisms by which it will 
have its desired effect(15). As Gitlin(15) suggests, the question, ‘why would this intervention 
work?’, is frequently overlooked.  Many feasibility trials now include mixed methods or 
process evaluations(16) to better understand not only ‘what’ to monitor and ‘how’, but to 
identify mechanisms of success, and factors likely to affect the outcome in a definitive trial. 
 
 
Reporting of interventions  
Incomplete intervention reporting is problematic for all evaluations of interventions, but 
particularly so for non-drug interventions, such as stroke rehabilitation(17). These complex 
interventions have long been described (inadequately) as ‘black boxes’(18). The 
consequences of this are numerous, with users of the research having to guess the 
components of the intervention. As a consequence, clinicians are unable to reliably replicate 
effective interventions and patients may miss out on receiving interventions in a manner 
that is faithful to what has been evaluated in trials. Researchers who wish to replicate 
evaluation of the intervention may be unable to do so. Also interpretation of the 
effectiveness of interventions in syntheses such as systematic reviews are hampered, and 
the useability of systematic reviews and clinical guidelines is compromised when original 
trials lack crucial details. In an analysis of a random sample of 60 systematic reviews of 
nonpharmacological stroke interventions, most reviews were missing intervention 
information for the majority of items(19). Incomplete intervention descriptions hinders 
research useability, replicability, and development of standardised rehabilitation 
interventions, which has been identified as priority for the world stroke agenda(20).  
 
 
 
Method 
 
SRRR Working group activities 
Identification of the intervention development, monitoring and reporting working group 
membership was conducted using a snowball technique by the SRRR steering committee 
with the aim of ensuring a global perspective. Efforts were made to incorporate stroke 
research leaders from Europe, North America, and Asia who had an interest and expertise in 
this area. Prior to the Roundtable meeting in Philadelphia, multiple teleconferences took 
place where the scope of the work was discussed and agreed, reading materials were 
shared and pre-workshop activities were delegated to working group members. Two co-
chairs (Walker and Hoffmann) of the group each led a strand of work and facilitated 
teleconferences and email discussions in preparation for a productive meeting in 
Philadelphia.  
 
In Philadelphia the group dedicated time to the discussion of each of the three areas: 
intervention development, monitoring, and reporting. Relevant literature and evidence 
were further shared and issues that were identified as limiting the progress of rehabilitation 
research were presented and discussed with the wider group membership. Discussions 
were recorded by a scribe and audio-taped. Two primary outputs were achieved: provisional 
group recommendations in each of the three areas; agreement on the validation work 
required to examine the extent to which contemporary stroke rehabilitation trials were 
aligned with the recommendations.  
 
During the discussions recommendations addressing issues identified as limiting stroke 
rehabilitation research were proposed. 
 
Exploration of recommendations in recently published papers. 
The SRRR working group acknowledged that many of the recommendations made had been 
documented elsewhere(4, 5, 7) but despite this, the group felt that the stroke rehabilitation 
research community would benefit from a stroke-specific output which collated previous 
and new recommendations made by the group.  To validate the need for our 
recommendations it was agreed that all stroke rehabilitation randomised controlled trials 
conducted over a recent twelve months period would be reviewed to ascertain if our 
recommendations had already been addressed by the stroke community. Our hypothesis 
was that a significant proportion of papers would not have addressed our 
recommendations.  
 
Identification of the sample 
We searched MEDLINE and CINAHL for studies published in 2015 using the terms 
“cerebrovascular accident” OR “cerebrovascular disease” OR “stroke”.  The search results 
were then paired using AND with keywords pertaining to any adult rehabilitation treatment. 
While it was expected that the term "rehabilitation" would find the majority of treatments, 
other keywords were generated and reviewed by X experts in stroke rehabilitation to be as 
inclusive as possible. To select only Randomised Controlled Trials (RCTs), we also paired 
using AND random* OR control*.   
 
The intervention terms were as follows:  
Activit* of Daily Living OR Acupuncture OR ADL OR Aerobic OR Antidepress* OR Ataxi* OR 
Aphasi* OR Balanc* OR Botox OR Botulin* OR Caregiver OR Cerebrolysin OR Chronic Disease 
Management OR Cogniti* OR Community Integration OR Conditioning OR Continence OR 
Contrain* OR Direct Current OR Dopamine OR Electric* Stimulation OR Exercis* OR FES OR 
Hand OR Homecare OR Incontinence OR Language OR Leisure OR Mental Practice OR Mirror 
OR Mobility OR Music OR Occupational Therapy OR Orthoses OR Percept* OR Physical 
Therapy OR Physio Therapy OR Postural Control OR Recreation OR Rehab OR Rehabilitation 
OR Respirat* OR Robot* OR Selective Serotonin Reuptake Inhibitor* OR Selegiline OR Self-
Management OR Sensory OR Shoulder OR Speech OR SSRI OR Supported Discharge OR Tele 
Rehab* OR Telehealth OR Telerehab* OR TMS OR Training OR Transcranial Magnetic 
Stimulation OR Transfer* OR Upper limb OR Vibrat* OR Virtual Reality OR Visu* OR 
Vocation* OR VR OR Wheelchair 
 
English language and human studies were used as restrictions.  Abstracts and conference 
posters were excluded. Titles, abstracts, and full-texts were screened by two independent 
reviewers. The original search resulted in 1437 articles from PubMed and 387 articles from 
CINAHL. After removing duplicates and those that did not meet the eligibility (i.e., RCT, 
rehabilitation intervention, published in 2015, adult stroke population), there were 182 
studies remaining. 
 
 
 
Procedure 
Each member of the SRRR group was assigned an equal number of articles to assess the 
content of the paper against the recommendations in Box 1. A structured rating template 
was developed and for each article, each recommendation was assessed as: fully described; 
partially described; not described; or not applicable, with space for any additional 
comments.  
 
Analysis 
The completed assessment of all 182 papers was entered into three Excel tables 
(intervention development, monitoring, and reporting) and descriptive statistics applied. 
Data were summarised in bar charts. 
 
 
Box 1 Recommendations 
 
Intervention development 
 Follow a structured framework for intervention development. This enhances 
accountability/acts as aide memoire. The particular framework to be used is dependent 
on the purpose and specific target/population/setting of the research 
 Co-design research where appropriate with key stakeholders (e.g. health care providers) 
and incorporate strong patient involvement 
 Underpin development with theoretical rationale (e.g. the biological basis for the 
intervention; behaviour change theory) 
 Describe routine practice in sufficient detail to facilitate in-depth understanding of ‘usual 
care’ (see reporting recommendations below). Methods to capture this may include: 
videos, non-participant observation, surveys and ideally at more than 1 centre 
 Provide a clear rationale for each component of the intervention. This should include 
details on: why the specific dose has been chosen, how often it should be administered, 
for how long, who delivers it, training required of person delivering it, participant 
selection (e.g. type of stroke, severity etc.), time-frame post-stroke, stage of recovery 
post-stroke 
 Provide a clear description of core intervention components that must be delivered (see 
reporting recommendations) 
 Describe the potentially variable contexts in which the intervention can be delivered 
 Consider and address issues which might affect the implementation of the intervention 
into clinical practice  
 Use iterative modelling prior to definitive evaluation (e.g. dose escalation studies). 
 
Intervention monitoring 
 Build an assessment of fidelity into the trial protocol (described in Item 11 of TIDieR) 
 Describe method for measuring fidelity that is trial and intervention-specific. No fidelity 
framework ideal for all situations.   
 Routinely report training of health professionals in delivering the intervention, as well as 
whether (and if so, how) their level of competence was assessed (described in Item 5 of 
TIDieR). 
 
Intervention Reporting 
 
 
Results 
Figure 1 shows the proportion of trials which addressed the recommendations for 
intervention development and monitoring.  As hypothesised, the majority of the 
recommendations were not described in most of the publications. In terms of intervention 
development, only 8% of studies fully or partially reported co-design of the research with 
stakeholders. Consideration of implementation issues during intervention development was 
 Follow the appropriate reporting guideline for study design type (e.g. SPIRIT for trial 
protocols; CONSORT for randomised trials) and the appropriate extension (e.g. extension 
for Cluster trials).  
- Refer to EQUATOR Network site (www.equator-network.org) for reporting guidelines 
 Provide the trial registration number in the article (preferably in the abstract) to facilitate 
linkage of related articles 
 Use TIDieR (an extension to SPIRIT and CONSORT) as a guide to ensure complete reporting 
of interventions: 
- Item 1: Brief name or phrase that describes the intervention 
- Item 2: Describes any rationale, theory, or goal of the elements essential to the 
intervention 
- Item 3: Describe physical or informational materials used in the intervention (provided to 
participants and/or used in training of providers) and where and how these can be 
accessed (and any requirements on their access and use) 
- Item 4: Describe each of the procedures, activities, and/or processes used in the 
intervention (including if it needs to be delivered in sequence/ step wise fashion/ staged) 
- Item 5: For each category of intervention provider (e.g. OT, psychologist, nurse), describe 
their expertise, background, any specific training given (& if employed by trial funding or 
health service) 
- Item 6: Describe the modes of delivery (e.g. face-to-face or remote contact such as 
telephone phone, internet, etc) and whether provided individually or in a group 
- Item 7: Describe the type/s of location/s where the intervention occurred, including any 
necessary infrastructure or relevant features 
- Item 8: When and how much of the intervention: describe the number of times the 
intervention was delivered and over what period of time, including the number of 
sessions, their schedule, and their duration, intensity or dose 
- Item 9: Tailoring: If the intervention was planned to be personalised, titrated or adapted, 
describe what, why, when, and how  
- Item 10: Modifications - If the intervention was modified during the course of the study, 
describe the changes (what, why, when, and how) 
- Item 11: Fidelity plans: If intervention adherence or fidelity was assessed, describe how 
and by whom, and if any strategies were used to maintain or improve fidelity, describe 
them 
- Item 12: Actual fidelity: If intervention adherence or fidelity was assessed, describe the 
extent to which the intervention was delivered as planned 
- Clearly describe (using TIDieR items 3-9) 'usual care' or the comparator in the trial to 
enable interpretation of trial results. 
 
 
addressed in only 12% of trials.  The majority of trials described when to give the 
intervention and the dose required to be administered, yet the iterative modelling required 
to optimise the intervention was scarcely reported with only 13% partially or fully reporting 
this. This brings into question if the phases required to fully understand the optimal dosage 
for stroke survivors was addressed before the onset of the trial. Over 80% of trials reported 
the theoretical rationale underpinning the trial intervention and a clear description of the 
core intervention components, but these aspects were rated as fully described in only 41% 
and 42% of trials respectively.   
 
Intervention monitoring was particularly poorly described across all three recommendations 
in this category. Thus, for the majority of trials it is unclear how interventions were 
monitored whilst the trials were in progress. 
 
[Insert Figure 1 Here] 
 
Overall, a higher proportion of trials addressed the reporting recommendations than the 
intervention development and monitoring recommendations, as shown in Figure 2. 
However, most papers addressed only one aspect of fidelity, such as adherence to a defined 
element of the protocol, for example acceptability or a measure of dose, intensity or 
duration.  Few considered factors such as programme drift, programme differentiation or 
competence.  Many different factors can potentially influence how an intervention is 
delivered and its outcome success. 
 
[Insert Figure 2 Here] 
 
 
Discussion 
The SRRR working group were cognisant of the limitations of the work undertaken which 
involved significant time constraints and resources and a limited pool of rehabilitation 
experts. Nonetheless it was felt that the consensus from an international group of stroke 
rehabilitation research experts was an important first step in trying to address the perceived 
shortfall in methodological and reporting weaknesses in rehabilitation research. 
Our review of recently published stroke rehabilitation RCT’s, has highlighted that the 
majority of publications did not clearly describe how interventions were developed or 
monitored during the trial. In particular, under-reporting of the theoretical rationale for the 
intervention and the components of the intervention calls into question many interventions 
that have been evaluated for efficacy.  
 
With regard to intervention reporting, more trials were found to have addressed these 
recommendations than those related to intervention development and monitoring. This 
may be due in part to the publication of the TIDieR guideline(7) and increased awareness 
and emphasis on intervention reporting.  Notwithstanding this, the majority of reporting 
recommendations were still not fully described in the vast majority of the published studies. 
Of particular concern is the lack of detail provided around intervention fidelity and usual 
care. Without knowing exactly what intervention was provided, and exactly what it was 
compared to (these factors were fully described in less than 10% of studies), the validity of 
results about the effectiveness of the interventions is clearly questionable. This should be of 
concern to the professional integrity of researchers working in the area of stroke 
rehabilitation.  
 
Funders of research generally provide limited support for developmental work, instead 
moving directly to feasibility phase II trials, with minimal reassurance that the essential 
intervention development phases have been completed, and that a rigorous intervention is 
ready to be evaluated for effectiveness. One potential solution to address this shortfall is by 
having MPhil and PhD studies focus more on the biological, and or theoretical basis for 
interventions followed by rigorous modelling to understand the optimal dosage and 
subgroups of patients who would benefit most. 
 
We acknowledge that the lack of detailed reporting regarding intervention development, 
monitoring, and reporting may not always mean that certain steps were not undertaken. 
Reporting omissions could instead be due to prioritisation regarding what to report within a 
manuscript with a finite word limit. However, as many journals accept additional detail as 
on-line supplements, our opinion is that this is no longer acceptable.  It may also be that this 
information may have been described elsewhere. We did not search for secondary/related 
articles. Complete reporting is often low on the priority list for authors, reviewers, and 
editors, and many do not know what constitutes complete reporting.  Moher and 
Altman(21) have proposed the development of core competencies and additional training 
for authors, peer reviewers, and editors with the aim of raising the reliability of published 
outputs in the medical literature.  
 
There appears to be little academic reward in detailing intervention fidelity, as considerably 
more publication space is dedicated to details regarding clinical outcomes following 
evaluation of an intervention. We know from our search that very few papers are published 
regarding intervention fidelity. However, we are not in a position to know whether papers 
dedicated to intervention development or trial fidelity are being written, submitted and not 
accepted for publication, or whether these aspects of clinical trials are either not being 
investigated or not written up. Questions remain about: Is intervention development being 
conducted systematically yet not reported, or are interventions that do not have sound 
biological or theoretical rationale for efficacy being evaluated?  Also we cannot be clear if 
fidelity is being monitored closely and not being reported, or is it sometimes overlooked?   
 
Fidelity is a crucial part of learning about efficacy of an intervention – and for positive trials, 
lessons learned through monitoring fidelity can often guide how an intervention can be 
applied in clinical practice, or can raise questions about mechanisms of action in a positive 
trial where lack of fidelity has been demonstrated. Accurate monitoring of intervention 
fidelity can require intensive resourcing, yet there seems to be little academic reward (in 
terms of high impact publications) in documenting this process. An exception to this rule are 
grants funded by the National Institute for Health Research (NIHR) in the UK, where 
researchers are required to create a 50,000 word monograph on completion of the study, 
which includes documenting a detailed description of intervention fidelity. Given the 
importance and complexity of ensuring intervention fidelity, it would be to the benefit of 
the academic community to create incentives to report fidelity, such as journals including 
papers dedicated to reporting intervention fidelity, or at a minimum, increasing the word 
limit or including in the on-line supplement and insisting intervention fidelity is reported for 
every clinical trial. 
 
In conclusion, we call to action the stroke rehabilitation research community to endorse our 
recommendations and to ensure that we develop, monitor and report the best evidence 
thereby maximising the chance of best care for our stroke patients.  They deserve no less. 
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